600763 通策医疗
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,410,5803.52%2,846,5082,718,6122,780,7252,087,865
减:营业总成本1,033,1354.68%2,199,9662,029,1511,873,0831,452,287
    其中:营业成本834,6464.44%1,749,7541,609,0251,500,0001,144,870
               财务费用22,64259.91%49,58946,55323,02015,227
               资产减值损失------------
公允价值变动收益------------
投资收益24,69010.26%60,19338,30156,13438,863
    其中:对联营企业和合营企业的投资收益16,94872.40%34,80010,74812,39613,086
营业利润407,7941.49%711,922733,906974,891678,640
利润总额406,9701.49%708,858737,984974,584680,066
减:所得税费用39,386-6.87%130,434122,306188,434135,104
净利润367,5842.48%578,423615,678786,150544,962
减:非控股权益57,7726.45%77,94967,40983,34352,336
股东净利润309,8121.77%500,475548,269702,807492,625

市场价值指针
每股收益 (元) *0.9702.11%1.5601.7102.1901.540
每股派息 (元) *----0.436------
每股净资产 (元) *12.3319.49%11.86710.3258.9846.706
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容